Morgan Stanley Sana Biotechnology, Inc. Transaction History

Morgan Stanley

$1.36 Trillion
Q1 2025

A detailed history of Morgan Stanley transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Morgan Stanley holds 825,664 shares of SANA stock, worth $1.41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

825,664

Previous 1,910,219 56.78%

Holding current value

$1.41 Million

Previous $3.11 Million 55.44%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$1.65 - $4.3 $1.79 Million - $4.66 Million	-1,084,555 Reduced 56.78%	825,664 $1.39 Million
Q4 2024 Feb 14, 2025	BUY	$1.6 - $4.36 $11,446 - $31,191	7,154 Added 0.38%	1,910,219 $3.11 Million
Q3 2024 May 14, 2025	BUY	$3.76 - $6.86 $1.07 Million - $1.95 Million	284,724 Added 17.59%	1,903,065 $7.92 Million
Q3 2024 Nov 14, 2024	BUY	$3.76 - $6.86 $1.07 Million - $1.95 Million	284,724 Added 17.59%	1,903,065 $7.92 Million
Q2 2024 May 14, 2025	SELL	$5.23 - $10.44 $1.53 Million - $3.05 Million	-291,878 Reduced 15.28%	1,618,341 $8.84 Million
Q2 2024 Oct 17, 2024	BUY	$5.23 - $10.44 $672,897 - $1.34 Million	128,661 Added 8.64%	1,618,341 $8.84 Million
Q2 2024 Aug 14, 2024	BUY	$5.23 - $10.44 $672,897 - $1.34 Million	128,661 Added 8.64%	1,618,341 $8.84 Million
Q1 2024 Oct 17, 2024	SELL	$4.2 - $11.27 $540,376 - $1.45 Million	-128,661 Reduced 7.95%	1,489,680 $14.9 Million
Q1 2024 Aug 16, 2024	BUY	$4.2 - $11.27 $3.18 Million - $8.52 Million	756,278 Added 103.12%	1,489,680 $14.9 Million
Q1 2024 May 15, 2024	BUY	$4.2 - $11.27 $3.18 Million - $8.52 Million	756,278 Added 103.12%	1,489,680 $14.9 Million
Q4 2023 Aug 16, 2024	SELL	$2.8 - $4.55 $2.48 Million - $4.03 Million	-884,939 Reduced 54.68%	733,402 $2.99 Million
Q4 2023 Feb 13, 2024	BUY	$2.8 - $4.55 $393,229 - $638,997	140,439 Added 23.68%	733,402 $2.99 Million
Q3 2023 Nov 15, 2023	BUY	$3.77 - $6.23 $11,837 - $19,562	3,140 Added 0.53%	592,963 $2.29 Million
Q2 2023 Aug 14, 2023	BUY	$3.22 - $7.53 $335,144 - $783,737	104,082 Added 21.43%	589,823 $3.52 Million
Q1 2023 May 15, 2023	BUY	$3.11 - $4.92 $116,895 - $184,928	37,587 Added 8.39%	485,741 $1.59 Million
Q4 2022 Feb 14, 2023	SELL	$3.19 - $6.46 $788,666 - $1.6 Million	-247,231 Reduced 35.55%	448,154 $1.77 Million
Q3 2022 Nov 14, 2022	SELL	$5.58 - $9.04 $1.29 Million - $2.09 Million	-231,638 Reduced 24.99%	695,385 $4.17 Million
Q2 2022 Oct 27, 2022	SELL	$4.12 - $9.35 $3.54 Million - $8.03 Million	-858,870 Reduced 48.09%	927,023 $5.96 Million
Q2 2022 Aug 15, 2022	SELL	$4.12 - $9.35 $3.54 Million - $8.03 Million	-858,870 Reduced 48.09%	927,023 $5.96 Million
Q1 2022 Oct 27, 2022	BUY	$5.24 - $15.58 $4.5 Million - $13.4 Million	858,870 Added 92.65%	1,785,893 $14.8 Million
Q1 2022 May 13, 2022	BUY	$5.24 - $15.58 $5.53 Million - $16.4 Million	1,055,116 Added 144.38%	1,785,893 $14.8 Million
Q4 2021 Feb 14, 2022	SELL	$15.18 - $23.15 $2.55 Million - $3.88 Million	-167,713 Reduced 18.67%	730,777 $11.3 Million
Q3 2021 Nov 15, 2021	BUY	$16.29 - $25.88 $14.6 Million - $23.3 Million	898,490 New	898,490 $20.2 Million

Others Institutions Holding SANA

# of Institutions

171

Shares Held

115M

Call Options Held

337K

Put Options Held

337K

View Full List

About Sana Biotechnology, Inc.

Ticker SANA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 190,232,000
Market Cap $325M
Description
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...

More about SANA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account